June 15, 2021
1 min read

‘AstraZeneca jab authorised for all age-groups’

The EU has also authorised Pfizer-BioNTech and Moderna’s mRNA based Covid-19 vaccines…reports Asian Lite News.

AstraZeneca’s Covid-19 vaccine remains authorised for all populations, European Medicines Agency (EMA) has said.

The clarification camme after Italian newspaper La Stampa earlier quoted Marco Cavaleri, head of the EMA’s vaccine strategy, recommending a stop to administration of AstraZeneca’s Covid shots in Europe to people aged over 60 and younger age groups, amid fears over very rare blood clotting.

“Misinformation is making the rounds today. This is the situation: Benefit/risk balance of AstraZeneca #Covid19 vaccine is positive and it remains authorised for all populations,” the EMA said in a tweet on Sunday.

Cavaleri was also quoted by the newspaper advising the use of the Johnson & Johnson vaccine preferentially for the over-60s.

The European Union has approved AstraZeneca and Johnson & Johnson vaccines for all populations aged 18 and above. However, both viral vector-based jabs have been marred by various reports of rare blood clots.

The EU has also authorised Pfizer-BioNTech and Moderna’s RNA based Covid-19 vaccines.
Asked by the newspaper whether it would be better to stop using AstraZeneca for all age groups, Cavaleri had said: “Yes, and it is an option that many countries, such as France and Germany, are considering in the light of the increased availability of mRNA vaccines.”

“However, incidents were very rare after the first dose. It is true that there is less data on the second dose, but in the United Kingdom it (the vaccination programme) is going well,” he added.

On June 11, Italy restricted the use of AstraZeneca doses to those aged 60 years and above, after a teenager who had received the shot died from a rare form of blood clotting.

In March, the two-dose vaccine was briefly halted by many European countries, including Italy, over concerns about the rare blood clotting problems.

But, its usage was resumed in April, after the EMA said its benefits outweighed any risks.

ALSO READ-Japan approves Moderna, AstraZeneca jabs

READ MORE-EU sues AstraZeneca for contract breach

Previous Story

Afghan forces capture key Taliban commander

Next Story

‘China’s three-child policy won’t prevent lower annual births’

Latest from -Top News

Modi Ends China Trip, US Hails India Ties

US termed India-US ties as a “defining relationship of the 21st century”, stating that partnership between both countries continues to reach new heights….reports Asian Lite News Shortly after videos and images of

India Snubs China’s BRI Again

India has refused to support China’s BRI during the previous SCO Summits as well….reports Asian Lite News On Monday, India once again withheld its support for China’s controversial Belt and Road Initiative

SCO Slams Pahalgam Terror Attack

In the Tianjin Declaration, SCO leaders offered condolences to families of the terror attack victims….reports Asian Lite News Shanghai Cooperation Organisation (SCO) member states strongly condemned the April 22 Pahalgam terror attack,

Modi Targets Nations Backing Terror at SCO summit

The Prime Minister reiterated India’s consistent opposition to terror financing and any support to extremist groups….reports Asian Lite News With Pakistan’s Prime Minister Shehbaz Sharif present, Prime Minister Narendra Modi on Monday
Go toTop

Don't Miss

Apex court grills government over vaccine policy

The bench emphasised that the vaccination not reaching the rural

EU urges China to launch probe into situation with Shuai

The IOC last week said in a statement that its